In a strategic move aimed at navigating recent challenges, Illumina, a leading genetic testing company, has announced the appointment of Jacob Thaysen as its new CEO. Thaysen, formerly of Agilent Technologies, brings a wealth of experience in the medical tools industry, particularly in the analytical instruments division. His tenure is set to commence on September […]
